Lycia Therapeutics (LYCA) News
NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
33.07+1.30 (+4.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LYCA news summary
We found 5 recent headlines mentioning Lycia Therapeutics (LYCA): 1 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Investing.com. For price context, LYCA is up 4.09% at $33.07. The most recent story, "Why is Lycia Therapeutics stock surging today?", was published by Investing.com on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Lycia Therapeutics headlines
- Why is Lycia Therapeutics stock surging today?Investing.com
- Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare ConferenceSOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel…GlobeNewswire
- Lycia Shares Fall Nearly 10% After Hours Following $365.1 Mln IPO Closing(RTTNews) - Shares of Lycia Therapeutics, Inc. (LYCA) fell nearly 10% in after-hours trading on Monday following the company's announcement that it closed its upsized initial public offering.NasdaqLYCA, BRK.A
- Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesSOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of…GlobeNewswire
- Biotech Stocks On Investor Radar - BOLT +66%, LYCA +33%, LUCD, GMAB(RTTNews) - Shares of several biotech companies moved higher following corporate, financing and clinical developments. Bolt Biotherapeutics gained after announcing a reverse merger with Prana…NasdaqBOLT, GMAB, LUCD, LYCA